id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0003-0081,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-324 Phenylpropanolamine,Supporting & Related Material,Freedom of Information Summary,2012-03-19T04:00:00Z,2012,3,,,2012-03-19T19:03:24Z,,0,0,0900006480fdb2bc
FDA-2011-N-0003-0080,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-331 Pergolide,Supporting & Related Material,Freedom of Information Summary,2012-03-19T04:00:00Z,2012,3,,,2012-03-19T16:43:41Z,,0,0,0900006480fda89d
FDA-2011-N-0003-0079,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Phenylpropanolamine,Rule,Final Rule,2012-03-19T04:00:00Z,2012,3,2012-03-19T04:00:00Z,,2012-03-19T16:36:30Z,2012-06553,0,0,0900006480fdac8f
FDA-2011-N-0003-0078,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Pergolide,Rule,Final Rule,2012-03-19T04:00:00Z,2012,3,2012-03-19T04:00:00Z,,2012-03-19T13:39:39Z,2012-06544,0,0,0900006480fdac97
FDA-2011-N-0003-0077,FDA,FDA-2011-N-0003,"Animal Drugs, Feeds, and Related Products: N-Methyl-2-Pyrrolidone; Correction",Rule,Correction,2012-02-17T05:00:00Z,2012,2,2012-02-17T05:00:00Z,,2012-02-17T14:12:13Z,2012-03747,0,0,0900006480fb8faf
FDA-2011-N-0003-0076,FDA,FDA-2011-N-0003,FDA/DDM Courtesy Letter to the Holders of Applications - Letter,Other,Letter(s),2012-02-16T05:00:00Z,2012,2,2012-02-16T05:00:00Z,,2012-02-16T23:45:05Z,,0,0,0900006480fac666
FDA-2011-N-0003-0075,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Chlortetracycline Powder,Rule,,2012-02-06T05:00:00Z,2012,2,2012-02-06T05:00:00Z,,2012-02-06T17:48:19Z,2012-02633,0,0,0900006480fae382
FDA-2011-N-0003-0073,FDA,FDA-2011-N-0003,"New Animal Drugs: Chloramphenicol, Diethylcarbamazine Citrate, Hygromycin B, Methoxyflurane, Neomycin Sulfate, Penicillin G, Phenylbutazone,etc.",Rule,Final Rule,2012-02-01T05:00:00Z,2012,2,2012-02-01T05:00:00Z,,2012-02-01T15:16:51Z,2012-02103,0,0,0900006480faacf8
FDA-2011-N-0003-0074,FDA,FDA-2011-N-0003,Withdrawal of Approval of New Animal Drug Applications,Notice,General Notice,2012-02-01T05:00:00Z,2012,2,2012-02-01T05:00:00Z,,2012-02-01T15:47:20Z,2012-02109,0,0,0900006480faacba
FDA-2011-N-0003-0063,FDA,FDA-2011-N-0003,Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:18:17Z,,0,0,0900006480fa722e
FDA-2011-N-0003-0067,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-207 - Danofloxacin,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:33:04Z,,0,0,0900006480fa7232
FDA-2011-N-0003-0062,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Gentamicin Sulfate,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:11:48Z,2012-01753,0,0,0900006480fa6f59
FDA-2011-N-0003-0065,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:24:50Z,,0,0,0900006480fa7230
FDA-2011-N-0003-0069,FDA,FDA-2011-N-0003,Freedom of Information Summary NADA 095-735 - Monensin,Supporting & Related Material,Freedom of Information Summary,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:00:40Z,,0,0,0900006480fa729f
FDA-2011-N-0003-0071,FDA,FDA-2011-N-0003,"Oral Dosage Form New Animal Drugs: Milbemycin Oxime, Lufenuron, and Praziquantel",Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:09:20Z,2012-01744,0,0,0900006480fa7022
FDA-2011-N-0003-0064,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:20:52Z,2012-01754,0,0,0900006480fa6f61
FDA-2011-N-0003-0072,FDA,FDA-2011-N-0003,"Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel",Supporting & Related Material,Reference (internal unless indicated),2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:12:54Z,,0,0,0900006480fa72a3
FDA-2011-N-0003-0068,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Monensin,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:56:44Z,2012-01755,0,0,0900006480fa6ff0
FDA-2011-N-0003-0070,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Name,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T15:05:48Z,2012-01756,0,0,0900006480fa6ff4
FDA-2011-N-0003-0066,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Danofloxacin,Rule,Final Rule,2012-01-27T05:00:00Z,2012,1,,,2012-01-27T14:27:44Z,2012-01743,0,0,0900006480fa6f98
FDA-2011-N-0003-0061,FDA,FDA-2011-N-0003,reedom of Information Summary NADA 141-203 Deracoxib,Supporting & Related Material,Freedom of Information Summary,2012-01-26T05:00:00Z,2012,1,,,2012-01-26T14:22:22Z,,0,0,0900006480fa50c0
FDA-2011-N-0003-0060,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Deracoxib,Rule,Final Rule,2012-01-26T05:00:00Z,2012,1,,,2012-01-26T14:09:02Z,2012-01622,0,0,0900006480fa5564
FDA-2011-N-0003-0058,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Spray,Rule,Final Rule,2012-01-25T05:00:00Z,2012,1,2012-01-25T05:00:00Z,,2012-01-25T21:11:07Z,2012-01501,0,0,0900006480fa3c14
FDA-2011-N-0003-0059,FDA,FDA-2011-N-0003,"Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary",Supporting & Related Material,Freedom of Information Summary,2012-01-25T05:00:00Z,2012,1,,,2012-01-25T21:52:45Z,,0,0,0900006480fa4961